Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery
- Conditions
- Urinary Incontinence
- Interventions
- Procedure: Vattikuti Urology Institute radical prostatectomyProcedure: Retzius sparing radical prostatectomyDevice: da Vinci Surgical System
- Registration Number
- NCT02352103
- Lead Sponsor
- Henry Ford Health System
- Brief Summary
To assess and compare the short-term post-operative continence recovery rate in two cohorts of men undergoing Robot Assisted Radical Prostatectomy (RARP), each randomized to undergo RARP with Vattikuti Institute technique or Retzius sparing technique.
- Detailed Description
Traditionally, RARP is performed using a trans-peritoneal technique that pass anteriorly to the bladder. This technique necessitates the dissection and/or manipulation of many structures, which might compromise post-operative urinary continence recovery. These structures include the pubo-prostatic ligament, Santorini plexus, neurovascular bundle, and veil of Aphrodite. Recently, a "Retzius-sparing" technique to perform RARP has beed described. This approach passes posteriorly to the bladder, through the space of Douglas, which should minimize the damaged to the aforementioned structure. Theoretically, the latter technique should improve post-operative urinary continence recovery. However, a randomized comparison between the "traditional" RARP and "Retzius-sparing" RARP is still lacking.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 120
- All patients with newly diagnosed prostate cancer undergoing robotic-assisted radical prostatectomy at the Vattikuti Urology Institute (performed by single surgeon, MM) as the primary treatment modality
- Be able to read and speak English and be able to provide written informed consent
- patients with high risk prostate cancer,defined as a biopsy Gleason score ≥8 and/or a pre-operative prostate specific antigen value ≥20 ng/ml.
- evidence of clinical nodal involvement (cN1) or metastatic disease (M1)
- patients participating in a competing study
- patients with pre-operative urinary incontinence.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Treatment arm da Vinci Surgical System Retzius sparing radical prostatectomy da Vinci Surgical System Control arm da Vinci Surgical System Vattikuti Urology Institute radical prostatectomy da Vinci Surgical System Control arm Vattikuti Urology Institute radical prostatectomy Vattikuti Urology Institute radical prostatectomy da Vinci Surgical System Treatment arm Retzius sparing radical prostatectomy Retzius sparing radical prostatectomy da Vinci Surgical System
- Primary Outcome Measures
Name Time Method Urinary Continence Recovery One week after the removal of the suprapubic urinary catheter 24-hour pad weights
- Secondary Outcome Measures
Name Time Method Number of Participants With Urinary Continence Recovery within 3 months from the intervention 0 pad per day
Number of Participants With Peri and Postoperative Complications 1-year median follow up Clavien-Dindo complications
Number of Participants Who Regained Potency Postoperatively (as Measured by Sexual Health Inventory for Men (SHIM) Score of 17 or Greater) 1-year median follow up SHIM ranges from 0-25 with higher scores indicating better sexual function; a score of \>=22 is normal and \>=17 is considered mild ED
Number of Participants Who Had Biochemical Recurrence (Post-operative Prostate-Specific Antigen (PSA) Value >=0.2 ng/ml) 1-year median follow up Patients without biochemical evidence of disease recurrence (i.e. postop PSA \>=0.2 ng/mL)
Post-operative Urinary Function and Urinary Function-related Quality of Life Within 3 months from the intervention International Prostatic Symptom Score (continuous score from 0-35, higher scores indicating worse urinary function)
Trial Locations
- Locations (2)
Henry Ford Hospital
🇺🇸Detroit, Michigan, United States
Henry Ford West Bloomfield Hospital
🇺🇸West Bloomfield, Michigan, United States